Echo Therapeutics Announces Positive Results of a Clinical Study Testing Symphony(TM) tCGM System in Patients with Type 1 and Type ... ( Study Demonstrates Improvement o...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Echo Therapeutics Announces Positive Results of a Clinical Study Testing Symphony(TM) tCGM System in Patients with Type 1 and Type 2 Diabetes

Date:11/19/2009

Study Demonstrates Improvement of Accuracy with New Biosensor

FRANKLIN, Mass., Nov. 19 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery, today announced positive results of a clinical study of its Symphony tCGM System in patients with Type 1 and Type 2 Diabetes. Echo's non-invasive Symphony tCGM System consists of its wireless transmission and transdermal biosensor technologies and its Prelude SkinPrep System, which incorporates leading-edge, needle-free, controlled skin ablation. Echo's Symphony tCGM System is designed to provide patients with diabetes and critical care patients with a reliable, affordable, and easy-to-use, needle-free continuous glucose monitoring device. The purpose of the study was to test the performance of its new, improved one-piece, cost-effective and easy-to-use biosensor.

"This study represents another major step forward in our Symphony development program," stated Patrick Mooney, M.D., Echo's Chairman and CEO. "We believe that we have successfully developed a new cost-effective, one-piece biosensor and, with this study, we have demonstrated improvement in the accuracy of our Symphony system glucose readings. Data from this study demonstrates that Symphony, using the new, improved, cost-effective biosensor, is safe, accurate and reliable at monitoring glucose levels. We look forward to continued progress with our Symphony development program throughout this year and next as we move toward our goal of making Symphony available to patients."

Study Design

After Prelude skin ablation, ten (10) Symphony tCGM biosensors were applied to subjects with Type 1 or Type 2 Diabetes. Venous reference blood samples were taken from
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Mersana Therapeutics Provides Clinical Update from Ongoing Phase 1 Study of XMT-1001 in Patients with Advanced Solid Tumors
2. Oxygen Biotherapeutics, Inc. Begins Shipping Cosmetic Product to Customers
3. Paloma Pharmaceuticals Presents at the AACR-NCI-EORTC International Conference Molecular Targets and Cancer Therapeutics
4. Senesco Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
5. Orexigen(R) Therapeutics to Speak at Lazard Capital Markets Healthcare Conference
6. Tobira Therapeutics Announces Presentation of TBR-652 Data at European AIDS Conference
7. Reportlinker Adds Pain Therapeutics 2005: Market Dynamics and Outlook
8. Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009
9. Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering
10. Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results
11. Echo Therapeutics Initiates Clinical Study of its New One-Piece Symphony(TM) tCGM Biosensor in Type 1 and Type 2 Diabetic Patients

Post Your Comments:

(Date:5/22/2013)... 2013 The new 13-valent pneumococcal conjugate vaccine ... version used prior to 2010, the 7-valent pneumococcal conjugate ... today in Vaccine. The U.S. Food and ... after a series of trials. These trials found that ... types than the previously used PCV7, did not increase ...

(Date:5/22/2013)... Mai 2013 Kepner-Tregoe (KT), das ... heute bekannt, dass der Veteran von 13 ... zum Hauptgeschäftsführer ernannt wurde. Geraghty,s Erfahrung umfasst ... er zahlreiche Führungspositionen bei Fertigungsunternehmen innehielt. Er ... der als Kepner-Tregoe Hauptgeschäftsführer gedient hat, in ...

(Date:5/22/2013)... 22, 2013 MGT Capital Investments, Inc. (NYSE MKT: ... the Second Annual Marcum LLP MicroCap Conference on Thursday, ... at the Grand Hyatt Hotel. ... will update investors and answer questions. (Logo: ... is scheduled to begin at 9:30 a.m. EDT. MGT,s ...

Breaking Medicine Technology:Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 2 Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 3 Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 4 Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 2 Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 3 MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2 MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3 MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4

[0] Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine [0] Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer [0] MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference

... 11 Caraco Pharmaceutical Laboratories, Ltd. (NYSE: ... and 100mg oxaliplatin injections, which are therapeutically equivalent to ... and Drug Administration (FDA) for Sun Pharma,s Abbreviated New ... the treatment of colon and rectal cancer. Oxaliplatin injections ...

... SANTA MARIA, Calif. , March 11 ... the Snap-On Smile® brand and all intellectual property surrounding ... LUMINEERS® Smile Design Studio, an ISO 9001 certified laboratory ... services. For over 30 years, DenMat has been providing ...

Cached Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R) 2 Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R) 3 DenMat(R) Adds New Versatility for Esthetic and Diagnostic Treatment Options with Snap-On Smile Acquisition 2 DenMat(R) Adds New Versatility for Esthetic and Diagnostic Treatment Options with Snap-On Smile Acquisition 3 DenMat(R) Adds New Versatility for Esthetic and Diagnostic Treatment Options with Snap-On Smile Acquisition 4

Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R)DenMat(R) Adds New Versatility for Esthetic and Diagnostic Treatment Options with Snap-On Smile Acquisition

(Date:5/22/2013)... York, NY (PRWEB) May 22, 2013 A ... Public Health has found that of young people who visited ... girls and youth who were obese were more likely to ... food choices. It also found that young people eating at ... were half as likely to use calorie information as those ...

(Date:5/22/2013)... CHARLOTTE, (PRWEB) May 22, 2013 The ... fight against muscular dystrophy at the annual Charlotte Muscle ... $300,000 to help Charlotte-area families living with muscle disease. ... this year's event to support MDA families,” said MDA ... heroes who were partnered with a "Buddy" to make ...

(Date:5/22/2013)... is a gender gap when it comes to behavior ... does not appear to exist in children in Asia. ... of self-regulation than boys. Self-regulation is defined as children,s ... and persist on a task. It has been linked ... by Oregon State University researchers. , In three ...

(Date:5/22/2013)... York (PRWEB) May 22, 2013 ... of the DePuy Pinnacle Hip Replacement System continue to ... Federal Court, Bernstein Liebhard LLP reports. According to ... DePuy Orthopaedics to produce monitoring reports associated with a ... company’s medical device marketing practices. Plaintiffs maintained in ...

(Date:5/22/2013)... May 22, 2013 Twenty student-led startup ... year participating in an intensive startup accelerator designed to ... or services and create local jobs as part of ... year the Edson initiative offers approximately 20 student teams ... mentorship and training to launch their for-profit, more-than-profit or ...

[0] STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds [0] Charlotte Muscle Team Event Raises $300,000 in the Fight Against Muscle Disease [0] 'Boys will be boys' in US, but not in Asia [0] DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation [0] ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort

... to autism. A study in this week's issue of ... more likely than those without it to have had ... Boston University identified 90 children with autism and compared ... medical histories, including when they had the measles, mumps, ...

... vision loss with lazy eye, but not in the eye affected ... loss in the normal eye in the future.// At least 2 ... eye. ,Many countries routinely screen for lazy eye. The ... that eye. Some, but not all, countries place high importance on ...

... their recent study compare between bypass surgery and stenting ... options for blocked coronary arteries. //Bypass surgery involves grafting ... Stenting involves introducing a metal device into the artery ... a group of 200 patients to either minimally-invasive bypass ...

... are given antibiotics after being hospitalized have a lower risk of ... from Croydon Hospital, England //say that the reduced risk was ... a role in heart disease. The effect was seen regardless of ... pylori or Chlamydia pneumoniae. ...

... one handful of almonds a day may improve your ... the risk of coronary heart disease by lowering cholesterol.// ... are generally not recommended for people who need to ... determine if almonds can reduce heart disease risk by ...

... survey observe that many people are still not very much aware ... account for about 4% of all malignancies. //The warning signs can ... a cure. But, as a survey by dental experts at New ... ,The survey was part of a three day oral cancer ...

Cached Medicine News:Health News:Almonds Improve Cholesterol 2

Latest discovery on Autism Screening of Lazy Eye Comparing heart disease treatments Antibiotics help heart patients Almonds Improve Cholesterol Awareness of oral cancer is low

Stab incision blades color coded for simple and accurate identification...

Smooth, round edges allow for safe manipulation within the eye. 1.1mm wide gradually tapers to .50 mm wide. 45, 1.1mm wide, gradually tapers to .50mm wide....

... has two perforations which enable ... various single or bilateral configurations ... drape has two perforations which ... to various single or bilateral ...

30, 6.0mm from end...

Medicine Products:

BD Micro-Sharp Blades and BD Micro-Unitome Knives BD Visitec Nucleus Spatulas BD Visidrape Drapes BD Visitec Irrigating Cannulas